# SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
Canonical URL: https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance
Ticker: SIBN
Company: Si-Bone
Source: Si-Bone
Published: 2026-05-11 20:09 EST
Original Source URL: https://investor.si-bone.com
## Summary

Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement in adjusted EBITDA First Quarter 2026 Financial Highlights (all   comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2% U.S.

## Article Body
Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement in adjusted EBITDA First Quarter 2026 Financial Highlights (all   comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2% U.S.
## Recent Company News
- 2026-05-11 20:09 EST — [SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance) — Source: Si-Bone
- 2026-04-30 20:09 EST — [SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-bofa-securities-2026-healthcare-conference-on-may-12-2026) — Source: Si-Bone
- 2026-04-20 20:09 EST — [SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-report-first-quarter-2026-financial-results-on-may-11-2026) — Source: Si-Bone
- 2026-02-23 21:09 EST — [SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-record-financial-results-for-the-fourth-quarter-2025-and-issues-2026-guidance) — Source: Si-Bone
- 2026-02-17 21:30 EST — [SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-td-cowen-46th-annual-health-care-conference-on-march-2-2026) — Source: Si-Bone
## Related News
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)
- 2026-07-22 12:30 EST — NRSN — [NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS](https://biopharmsignal.com/news/NRSN/neurosense-advances-primec-toward-new-drug-submission-to-health-canada-for-als-721c198c)